Bin Wan Mohd Nor W, Kwong S, Fuzi A, Said N, Jamil A, Lee Y
Int J Mol Med. 2025; 55(3).
PMID: 39820715
PMC: 11759585.
DOI: 10.3892/ijmm.2025.5487.
Soldati G, Saccardo C, Raniero D, De Leo D, Turrina S
Int J Legal Med. 2024; 139(1):61-65.
PMID: 39377931
PMC: 11732918.
DOI: 10.1007/s00414-024-03341-w.
Georvasili V, Markopoulos G, Lampri E, Lianos G, Vartholomatos G, Mitsis M
J Clin Med. 2024; 13(16).
PMID: 39200895
PMC: 11355755.
DOI: 10.3390/jcm13164753.
Fan W, Su F, Zhang Y, Zhang X, Du Y, Gao Y
Biomark Res. 2024; 12(1):89.
PMID: 39183366
PMC: 11346251.
DOI: 10.1186/s40364-024-00640-7.
Yan L, Shi J, Zhu J
Discov Oncol. 2024; 15(1):294.
PMID: 39031216
PMC: 11265098.
DOI: 10.1007/s12672-024-01163-1.
Natural products can be potential inhibitors of metalloproteinase II from to intervene colorectal cancer.
Arif B, Yasir S, Saeed M, Fatmi M
Heliyon. 2024; 10(12):e32838.
PMID: 39005891
PMC: 11239599.
DOI: 10.1016/j.heliyon.2024.e32838.
High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations.
Heriyanto D, Yoshuantari N, Akbariani G, Lau V, Hanini H, Hidayati Z
World J Oncol. 2024; 15(4):612-624.
PMID: 38993255
PMC: 11236368.
DOI: 10.14740/wjon1843.
Clinicopathological and molecular features of genome-stable colorectal cancers.
Jin L, Jin H, Kim Y, Cho N, Bae J, Kim J
Histol Histopathol. 2024; 40(3):381-388.
PMID: 38993017
DOI: 10.14670/HH-18-785.
Treatment of Microsatellite-Unstable Rectal Cancer in Sporadic and Hereditary Settings.
Anderson C, Liska D
Clin Colon Rectal Surg. 2024; 37(4):233-238.
PMID: 38882941
PMC: 11178385.
DOI: 10.1055/s-0043-1770717.
High-Throughput Mass Spectrometry Analysis of -Glycans and Protein Markers after Knockdown in the Syngeneic SW480/SW620 Colorectal Cancer Cell Model.
Lopez-Cortes R, Muinelo-Romay L, Fernandez-Briera A, Gil Martin E
J Proteome Res. 2024; 23(4):1379-1398.
PMID: 38507902
PMC: 11002942.
DOI: 10.1021/acs.jproteome.3c00833.
The effect of novel nitrogen-based chalcone analogs on colorectal cancer cells: Insight into the molecular pathways.
Hassan A, Hussein O, Al-Barazenji T, Allouch A, Kamareddine L, Malki A
Heliyon. 2024; 10(5):e27002.
PMID: 38463818
PMC: 10923686.
DOI: 10.1016/j.heliyon.2024.e27002.
and Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort.
Habashy P, Lea V, Wilkinson K, Wang B, Wu X, Roberts T
Int J Mol Sci. 2023; 24(24).
PMID: 38139338
PMC: 10743527.
DOI: 10.3390/ijms242417509.
Analyzing aberrant DNA methylation in colorectal cancer uncovered intangible heterogeneity of gene effects in the survival time of patients.
Hajebi Khaniki S, Shokoohi F, Esmaily H, Kerachian M
Sci Rep. 2023; 13(1):22104.
PMID: 38092774
PMC: 10719305.
DOI: 10.1038/s41598-023-47377-1.
Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy.
Kashyap M, Mangrulkar S, Kushwaha S, Ved A, Kale M, Wankhede N
Pharmaceuticals (Basel). 2023; 16(10).
PMID: 37895912
PMC: 10610064.
DOI: 10.3390/ph16101441.
Diagnosis of patients with Lynch syndrome lacking the Amsterdam II or Bethesda criteria.
Trujillo-Rojas M, Ayala-Madrigal M, Gutierrez-Angulo M, Gonzalez-Mercado A, Moreno-Ortiz J
Hered Cancer Clin Pract. 2023; 21(1):21.
PMID: 37864171
PMC: 10589993.
DOI: 10.1186/s13053-023-00266-0.
Organoids and metastatic orthotopic mouse model for mismatch repair-deficient colorectal cancer.
Song Y, Kerr T, Sanders C, Dai L, Baxter S, Somerville B
Front Oncol. 2023; 13:1223915.
PMID: 37746286
PMC: 10516605.
DOI: 10.3389/fonc.2023.1223915.
Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S, Kahraman Cetin N, Erdogdu I, Meteoglu I
Turk J Gastroenterol. 2023; 34(11):1124-1133.
PMID: 37737217
PMC: 10724784.
DOI: 10.5152/tjg.2023.22682.
RSPO2 as Wnt signaling enabler: Important roles in cancer development and therapeutic opportunities.
Srivastava A, Rikhari D, Srivastava S
Genes Dis. 2023; 11(2):788-806.
PMID: 37692504
PMC: 10491879.
DOI: 10.1016/j.gendis.2023.01.013.
Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC-1α to reduce apoptosis in vitro and in vivo.
Xie M, Xia B, Xiao L, Yang D, Li Z, Wang H
J Cell Mol Med. 2023; 27(19):2945-2955.
PMID: 37494130
PMC: 10538260.
DOI: 10.1111/jcmm.17871.
Analyzing aberrant DNA methylation in Colorectal cancer uncovered intangible heterogeneity of gene effects in the survival time of patients.
Hajebi Khaniki S, Shokoohi F, Esmaily H, Kerachian M
Res Sq. 2023; .
PMID: 37397988
PMC: 10312929.
DOI: 10.21203/rs.3.rs-2957915/v1.